As per our report, the size of the global stem cell market is estimated to worth USD 14,380 Million in 2020. This value is forecasted to grow USD 25,820 Million by the end of 2024 with a CAGR of 12.42%, during the forecast period. The market to increase because of the extensive research and development, which is gaining significant importance.
In multicellular organisms, stem cells have a unique ability to regenerate into the specific cell to form different tissues in the body. These cells can work as a replacement in place of damaged tissues cells and have full applications in the field of healthcare. It has been accepted throughout the world.
Regenerative medicine is possibly the most important use of stem cells, and other essential areas comprise cardiology, neurology, orthopaedics, haematology, and oncology. Another widely used application is drug discovery and growth. Stem cells are kind of a research tool because in vitro study would allow scientists to deeply understand the role of various organs and the development of particular diseases. Stem cell therapy has shown significant potential to treat cancer successfully.
MARKET DRIVERS
Rising adoption of stem cells in the treatment of cancer is the primary factor driving market growth.
According to WHO cancer is the second leading cause of death globally, it is estimated that around 9.6 million deaths in 2018. The research is going on to treat cancer using stem cell, which is to fuel the demand of the market. For Instance, the somatic stem cell therapy or the bone marrow transplant is a procedure used for the treatment leukaemia (blood cancer) as bone marrow has a large number of stem cell.
Growing research activities using the stem cells to develop new therapies to expand treatment options for various diseases and increasing adoption of using these cells to replace the damaged tissue cells are propelling the global stem cell market growth. For Instance, the umbilical cord is to be discarded as a by-product of the birth process, but it was found that the blood in the umbilical cord is stem cell-rich and can be used for the treatment of different 80 diseases in the human body.
New stem cell banks are coming up to fulfil the increasing demand for stem cell storage. Thus the entry of new players is anticipated to boost up the need of the market. Different cell lines are used to develop a vaccine against infection. The increasing awareness about the use of stem cell is propelling the market growth.
MARKET RESTRAINTS
The most significant restraints of the stem cell market are the cost required for the storage and maintenance of the stem cell is comparatively more. The research needs a lot of funding, and a small error in the research can cost a lot. It required a skilled workforce which is very hard to get in this competitive market. Additionally, the controversy regarding the ethics in the research and the complexities related to the stem cell procedure are some other factors affecting the market growth.
Europe is known for its exceptional research quality and strength of product pipelines. Japan was one of the pioneers in the field of iPS research. HEALIOS K.K., a Japanese-based pharmaceutical company, is one of the first companies to test iPS treatment in the country. The company plans to market its product by 2022. Such initiatives are boosting the Jarevenue generation in the region.
The improved quality of differentiated cells as a result of efficient manufacturing owing to the collaborations is likely to expand growth opportunities for the stem cell market. The market to receive growth opportunities through the integration of different fields like materials, devices, chemical compounds, and biologics during the forecast period.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analyzed |
By Treatment Mode, Cell Type, Technology Segment and Region |
|
Various analyses covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analyzed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global stem cell market has been segmented and sub-segmented based on treatment mode, cell type, technology segment and region.
Stem Cell Market - By Treatment Mode:
Based on treatment mode, allogeneic therapy is estimated to cover the majority of the market share during the forecast period. The allogeneic cell can produce its immune cell, which inhibits the growth of the cancer cell. It is used to stop the reoccurrence of cancer.
Besides, the autologous stem cell therapy is also predicted to see promising growth in the coming years. It is used for the treatment of the people to treat damaged bone marrow.
Stem Cell Market - By Cell Type:
Based on the cell type, the segment is dominated by the adult stem cell segment as they are used for the treatment of cancer. The induced pluripotent stem has the second largest market share; it is used in the research to discover the premature ageing, congenital heart disease and cancer. Regenerative medicine is also a growing segment for the treatment of Alzheimer and Parkinson. The human embryonic stem cells segment is also growing as the number of cord cell preservation is increasing.
Stem Cell Market - By Technology:
Based on technology, the cell acquisition segment has acquired the largest market share in the recent past. The cell acquisition technique is used to extract bone marrow stem cell and to replace bone marrow.
Regional Analysis
North America is dominating the global stem cell market. This region is to maintain the trend due to increasing awareness about the therapeutic potential of stem cells, increasing funds for research, and improve in several clinical trials for stem-cell-based products.
However, the Asia-Pacific stem cell therapy market to grow the fastest in this forecast period, mainly because of better regulatory support through encouraging government policies and increasing awareness among the public. APAC Stem Cell Market to have decent growth opportunities with the rising incidences of infection. Also, the development of vaccines using various human diploid and non-tumorigenic cell lines is to escalate the demand of the market. Ongoing research and development of different disease vaccines are some of the factors expected to drive market growth during the forecast period.
TOP COMPANIES IN THE MARKET
List of key companies leading the global stem cell market profiled in this report are Athersys, StemCells, Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences, Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.
RECENT MARKET DEVELOPMENTS
Research on mesenchymal stem cells was carried out in 2019 by the research professionals at the University of Freiberg.
Mesoblast Company is collaborating with Grunenthal Inc. to develop innovative cell therapy for treating chronic low back pain. Grunanthal acquired rights from Mesoblast to commercialize MPC-06-ID in Latin America and Europe.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By mode of treatment
5.1.1 Autologous
5.1.2 Allogeneic
5.2 By application
5.2.1 CNS
5.2.2 CVS
5.2.3 GIT
5.2.4 Regenerative Medicine
5.2.5 Musculoskeletal
5.2.6 Eye & Immune System Development
5.2.7 Blood Disorders
5.3 By technology
5.3.1 Cell Acquisition
5.3.2 Cell Production
5.3.3 Cryopreservation
5.3.4 Expansion
5.3.5 Sub-Culture
5.4 By type
5.4.1 Adult Stem Cells
5.4.2 Human Embryonic Cells
5.4.3 Pluripotent Stem Cell
5.4.4 Natural Rosette Cells
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Athersys
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Cryo Cell International
8.4 Geron Corporation
8.5 Mesoblast
8.6 Aastrom Biosciences
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
